Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function

Neurology

Volumn 61, Issue 11 SUPPL. 6, 2003, Pages

  Rosin, Diane L ^a   Hettinger, Barbara D ^a   Lee, Amy ^a,b   Linden, Joel ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; ANTIBODY; DOPAMINE 2 RECEPTOR; GLUTAMATE TRANSPORTER; MESSENGER RNA; PRESYNAPTIC RECEPTOR; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; ADENOSINE A2A RECEPTOR;

ARTICLE; BASAL GANGLION; BRAIN REGION; CHOLINERGIC TRANSMISSION; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE FIBER; NEUROANATOMY; NEUROPIL; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRIATE CORTEX; SYNAPSE; ULTRASTRUCTURE; ANIMAL; BIOSYNTHESIS; BRAIN; CORPUS STRIATUM; DENDRITE; HISTOLOGY; METABOLISM; NERVE CELL; REVIEW;

ANIMALS; BASAL GANGLIA; BRAIN; CORPUS STRIATUM; DENDRITES; HUMANS; NEURONS; RECEPTOR, ADENOSINE A2A;

EID: 0345168910     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000095205.33940.99     Document Type: Article

References (64)

1. Ferre S, O'Connor WT, Snaprud P, Ungerstedt U, Fuxe K. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 1994;63:765-773.
2. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 1997;18:338-344.
3. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997;20:482-487.
4. Fink JS, Weaver DR, Rivkees SA, et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 1992;14:186-195.
5. Schiffmann SN, Jacobs O, Vanderhaeghen JJ. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 1991;57:1062-1067.
6. Ferre S, Fuxe K, von Euler G, Johansson B, Fredholm BB. Adenosine-dopamine interactions in the brain. Neuroscience 1992;51:501-512. Review.
7. Jarvis MF, Williams M. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680. Eur J Pharmacol 1989;168:243-246.
8. Parkinson FE, Fredholm BB. Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand. Naunyn Schmiedebergs Arch Pharmacol 1990;342:85-89.
9. Wan W, Sutherland GR, Geiger JD. Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J Neurochem 1990;55:1763-1771.
10. Martinez-Mir MI, Probst A, Palacios JM. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 1991;42:697-706.
11. Nonaka H, Mori A, Ichimura M, et al. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. Mol Pharmacol 1994;46:817-822.
12. Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 1997;27:322-335.
13. 2A receptor antagonist, is a useful ligand in autoradiographic studies. J Neurochem 1998;70:1210-1216.
14. 2A receptors: an overview. Brain Res Rev 1999;31:65-82.
15. 2A receptors. Prog Neurobiol 1999;59:355-396.
16. 2A receptors in the rat central nervous system. J Comp Neurol 1998;401:163-186.
17. Schiffmann SN, Libert F, Vassart G, Vanderhaeghen JJ. Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett 1991;130:177-181.
18. Augood SJ, Emson PC. Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a coexpression study. Brain Res Mol Brain Res 1994;22:204-210.
19. Dixon AK, Gubitz AK, Sirinathsinghji DJS, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996;118:1461-1468.
20. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 1997;80:1171-1185.
21. Svenningsson P, Le Moine C, Aubert I, Burbaud P, Fredholm BB, Bloch B. Cellular distribution of adenosine A(2A) receptor mRNA in the primate striatum. J Comp Neurol 1998;399:229-240.
22. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J Neurosci 1993;13:1080-1087.
23. 2A receptors-where are they? What do they do? Trends Pharmacol Sci 1998;19:46-47.
24. 2A receptors-where are they? What do they do? Reply. Trends Pharmacol Sci 1998;19:47-48.
25. Ferré S. Adenosine-dopamine interactions in the ventral striatum-implications for the treatment of schizophrenia. Psychopharmacology (Berl) 1997;133:107-120.
26. Fuxe K, Ferre S, Zoli M, Agnati LF. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Brain Res Rev 1998;26:258-273. Review.
27. 2 receptor knockout mice. Proc Natl Acad Sci USA 2001;98:1970-1975.
28. Franco R, Ferré S, Torvinen M, et al. Adenosine/dopamine receptor-receptor interactions in the central nervous system. Drug Dev Res 2001;52:296-302.
29. Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990;13:259-265.
30. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 1992;15:133-139.
31. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:244-254.
32. Graybiel AM. The basal ganglia. Trends Neurosci 1995;18:60-62.
33. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995;18:527-535.
34. Kawaguchi Y. Neostriatal cell subtypes and their functional roles. Neurosci Res 1997;27:1-8. Review.
35. Bolam JP, Hanley JJ, Booth PAC, Bevan MD. Synaptic organisation of the basal ganglia. J Anat 2000;196:527-542.
36. Hettinger BD, Lee A, Linden J, Rosin DL. Ultrastructural localization of adenosine A(2A) receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 2001;431:331-346.
37. Mayfield RD, Suzuki F, Zahniser NR. Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem 1993;60:2334-2337.
38. Kirk IP, Richardson PJ. Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release. J Neurochem 1994;62:960-966.
39. 2 receptor interaction in globus pallidus. Synapse 1996;22:132-138.
40. Kurokawa M, Kirk IP, Kirkpatrick KA, Kase H, Richardson PJ. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Br J Pharmacol 1994;113:43-48.
41. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 1996;16:605-611.
42. 2A receptor antagonists for a novel therapy in Parkinson's disease. Neurology 2003;61(Suppl 6):S44-S48.
43. 2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience 2000;100:53-62.
44. A-mediated IPSCs in the rat globus pallidus. J Physiol (Lond) 2001;532:423-434.
45. Wilson CJ, Groves PM. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. J Comp Neurol 1980;194:599-615.
46. Somogyi P, Bolam JP, Smith AD. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure. J Comp Neurol 1981;195:567-584.
47. Yung KKL, Smith AD, Levey AI, Bolam JP. Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur J Neurosci 1996;8:861-869.
48. Tunstall MJ, Oorschot DE, Kean A, Wickens JR. Inhibitory interactions between spiny projection neurons in the rat striatum. J Neurophysiol 2002;88:1263-1269.
49. Norenberg W, Wirkner K, Illes P. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br J Pharmacol 1997;122:71-80.
50. 2A receptors of NMDA but not AMPA currents in rat neostriatal neurons. Br J Pharmacol 2000;130:259-269.
51. 2A antagonist KW6002 from animal models to parkinsonian patients. Neurology 2003;61(suppl 6): S107-S111.
52. Ferré S, Karcz-Kubicha M, Hope BT, et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 2002;99:11940-11945.
53. 2A receptor signaling: Relevance for striatal function and Parkinson's disease. Neurology 2003;61(suppl 6): S19-S23.
54. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 1995;287:215-217.
55. Bellocchio EE, Reimer RJ, Fremeau RT Jr, Edwards RH. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 2000;289:957-960.
56. Bellocchio EE, Hu H, Pohorille A, Chan J, Pickel VM, Edwards RH. The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci 1998;18:8648-8659.
57. Bai LQ, Xu H, Collins JF, Ghishan FK. Molecular and functional analysis of a novel neuronal vesicular glutamate transporter. J Biol Chem 2001;276:36764-36769.
58. Fremeau RT Jr, Troyer MD, Pahner I, et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001;31:247-260.
59. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000;407:189-194.
60. Gras C, Herzog E, Bellenchi GC, et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002;22:5442-5451.
61. Herzog E, Bellenchi GC, Gras C, et al. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 2001;21:NIL1-NIL6.
62. I transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J Neurosci 2002;22:142-155.
63. Schafer MKH, Varoqui H, Defamie N, Weihe E, Erickson JD. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 2002;50734-50748.
64. Fremeau RT Jr, Burman J, Qureshi T, et al. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA 2002;99:14488-14493.